Akre Capital Management LLC

Institutional investor · Portfolio as of Q2 2026

Top Holdings20 positions

Checking export access…
Activity:
MA

Mastercard Incorporated

2M$1B20.0%$186.82+252.66%
31 qtrssince 2018-Q4
Decreased
0
MCO

Moody's Corporation

1.2M$524M10.2%$133.36+279.84%
31 qtrssince 2018-Q4
Decreased
0
BN

Brookfield Corporation

12.1M$516.2M10.1%$21.26+95.84%
15 qtrssince 2022-Q4
Decreased
0
KKR

KKR & Co. Inc.

5M$457.2M8.9%$24.39+298.50%
31 qtrssince 2018-Q4
Decreased
0
FICO

Fair Isaac Corporation

361,826$432.3M8.4%$1,411.92-49.19%
5 qtrssince 2025-Q2
Decreased
0
ROP

Roper Technologies, Inc.

1.2M$398.1M7.8%$280.35+70.45%
31 qtrssince 2018-Q4
Decreased
0
V

Visa Inc.

1.1M$381.1M7.4%$126.66+233.96%
31 qtrssince 2018-Q4
Decreased
0
CSGP

CoStar Group, Inc.

11.7M$331.3M6.5%$61.68-51.20%
27 qtrssince 2019-Q4
Increased
71
CPRT

Copart, Inc.

8M$225.1M4.4%$42.75-25.15%
5 qtrssince 2025-Q2
Decreased
0
ORLY

O'Reilly Automotive, Inc.

2.2M$199.1M3.9%$22.96+298.70%
31 qtrssince 2018-Q4
Decreased
0
ABNB

Airbnb, Inc.

1.2M$169.4M3.3%$133.81+35.36%
9 qtrssince 2024-Q2
Decreased
0
CCC

CCC Intelligent Solutions Holdings Inc.

29.9M$154.1M3.0%$9.01-14.61%
10 qtrssince 2024-Q1
Decreased
0
NOW

ServiceNow, Inc.

1.2M$123.7M2.4%$103.92-3.13%
2 qtrssince 2026-Q1
Increased
62
CRM

Salesforce, Inc.

717,799$112.5M2.2%$185.40+17.35%
2 qtrssince 2026-Q1
Unchanged
0
GSHD

Goosehead Insurance, Inc.

443,385$21.5M0.4%$54.99-16.97%
31 qtrssince 2018-Q4
Unchanged
0
SOPH

SOPHiA GENETICS SA

3.7M$21.5M0.4%——
10 qtrssince 2024-Q1
Unchanged
0
CRM
CRM
CALL

Salesforce, Inc.

100,000$15.7M0.3%———
Unchanged
—
PRM

Perimeter Solutions, SA

250,000$8.9M0.2%$24.42+21.33%
2 qtrssince 2026-Q1
Unchanged
0
AMT
AMT
REIT

American Tower Corporation

29,254$4.8M0.1%$129.77+46.25%
31 qtrssince 2018-Q4
Decreased
0
BRK/B

Berkshire Hathaway Inc.

8,184$4.1M0.1%$207.00+184.95%
31 qtrssince 2018-Q4
Decreased
0
$5.1B
AUM
20
Positions
Q2 2026
Filing
HI rating · 4.5/5
Quarterly 13F Value Change
Reported 13F value ($B)
Reported 13F values and quarter-over-quarter reported value changes; not investment returns.
QuarterReported value in US dollarsReported value change
2025-Q1$10,400,552,669-10.0382811215%
2025-Q2$10,210,810,464-1.82434733075%
2025-Q3$10,030,655,183-1.764358291%
2025-Q4$9,120,742,965-9.07131390123%
2026-Q1$6,134,537,825-32.7408101671%
2026-Q2$5,122,536,308-16.4967850206%
Activity profile
$ moved · Q2'26
New0%Increased9%Decreased91%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 4.6 years
<1Q0%1-4Q15%1-2Y10%2Y+75%

Akre Capital Management LLC manages $5.1B across 20 positions as of Q2 2026. Top holdings: MA (20.0%), MCO (10.2%), BN (10.1%). Fund DNA: Concentrated Value. HoldingsIntel Score: 4.5/5.0.

Q2 2026 Summary

Increased 2, led by CSGP (+1.4M shares); trimmed 13, led by BN (−4.9M shares). Top move: CSGP (INCREASED, conviction 71). Portfolio: $5.1B across 20 positions.

Top holdings by portfolio weight

Total AUM$5B
MA19.95%
MCO10.23%
BN10.08%
KKR8.93%
FICO8.44%
ROP7.77%
V7.44%
CSGP6.47%
CPRT4.39%
ORLY3.89%
Other3.31%

Portfolio allocation by GICS sector

Sectors7
Financial Services57.30%
Technology23.90%
Consumer Cyclical7.22%
Real Estate6.58%
Industrials4.41%
Healthcare0.42%
Basic Materials0.17%

Behavioral investing profile

Checking access…
Concentrated Value- primarily Financial Services, Technology
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Elite(4.5 / 5.0)
Holdings P&L73
Conviction69
Concentration100
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
3Q
CSGPCSGPCoStar Group, Inc.
Q4 2025 → Q2 2026+2.4M shares-$453.9M
Checking access…

Famous Investors' Portfolios

What the most-followed managers hold, and what they bought and sold each quarter.

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Optional analytics helps us improve. How it’s used